title: Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.
abstract: The different long-chain fatty acid oxidation defects present with similar heterogeneous clinical phenotypes of different severity. Organs mainly affected comprise the heart, liver, and skeletal muscles. All symptoms are reversible with sufficient energy supply. In some long-chain fatty acid oxidation defects, disease-specific symptoms occur. Only in disorders of the mitochondrial trifunctional protein (TFP) complex, including long-chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase (LCHAD) deficiency, neuropathy and retinopathy develop that are progressive and irreversible despite current treatment measures. In most long-chain fatty acid oxidation defects, no clear genotype-phenotype correlation exists due to molecular heterogeneity. However, some isolated mutations have been identified to be associated with only mild phenotypes, e.g., the V243A mutation in very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. LCHAD deficiency is due to the prevalent homozygous 1528G>C mutation and presents with heterogeneous clinical phenotypes, suggesting the importance of other environmental and genetic factors. For some disorders, it was shown that residual enzyme activity measured in fibroblasts or lymphocytes correlated with severity of clinical phenotype. Implementation of newborn screening has significantly reduced morbidity and mortality of long-chain fatty acid oxidation defects. However, the severest forms of TFP deficiency are still highly associated with neonatal death. Newborn screening also identifies a great number of mildly affected patients who may never develop clinical symptoms throughout life. However, later-onset exercise-induced myopathic symptoms remain characteristic clinical features of long-chain fatty acid oxidation defects. Disease prevalence has increased with newborn screening.
authors.affiliation: Department of General Pediatrics, University Children's Hospital, Duesseldorf, Germany. ute.spiekerkoetter@uni-duesseldorf.de
authors.forename: Ute
authors.initials: U
authors.lastname: Spiekerkoetter
mesh_terms: D004734:Energy Metabolism / Q000235:genetics; D005227:Fatty Acids / Q000378:metabolism*; D005838:Genotype; D006801:Humans; D007231:Infant, Newborn; D008052:Lipid Metabolism, Inborn Errors / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology / Q000235:genetics / Q000401:mortality; D008928:Mitochondria / Q000201:enzymology*; D028361:Mitochondrial Diseases / Q000150:complications / Q000175:diagnosis* / Q000201:enzymology / Q000235:genetics / Q000401:mortality; D015997:Neonatal Screening; D010084:Oxidation-Reduction; D010641:Phenotype; D012720:Severity of Illness Index
chemical_list: D005227:Fatty Acids
references.citation: J Inherit Metab Dis. 1999 Jun;22(4):442-87
references.pmid: 10407780
references.citation: J Inherit Metab Dis. 2009 Aug;32(4):488-97
references.pmid: 19399638
references.citation: Ophthalmology. 1998 May;105(5):810-24
references.pmid: 9593380
references.citation: Pediatr Cardiol. 2003 May-Jun;24(3):295-7
references.pmid: 12457256
references.citation: Mol Genet Metab. 2008 Jan;93(1):5-6
references.pmid: 17988913
references.citation: Am J Med Genet A. 2008 Nov 15;146A(22):2925-8
references.pmid: 18925671
references.citation: Mol Genet Metab. 2009 Mar;96(3):85-90
references.pmid: 19157942
references.citation: Am J Hum Genet. 1999 Feb;64(2):479-94
references.pmid: 9973285
references.citation: Muscle Nerve. 2004 Jan;29(1):66-72
references.pmid: 14694500
references.citation: J Inherit Metab Dis. 2003;26(6):613-5
references.pmid: 14605509
references.citation: J Biol Chem. 2005 Sep 16;280(37):32309-16
references.pmid: 16020546
references.citation: PLoS One. 2009 Jul 30;4(7):e6449
references.pmid: 19649258
references.citation: Mol Genet Metab. 2007 Jun;91(2):138-47
references.pmid: 17374501
references.citation: Biochem Biophys Res Commun. 2006 Jul 21;346(1):33-7
references.pmid: 16750164
references.citation: J Neurol Sci. 1989 Sep;92(2-3):229-45
references.pmid: 2809620
references.citation: Hum Mutat. 2001 Sep;18(3):169-89
references.pmid: 11524729
references.citation: Pediatr Res. 2004 Feb;55(2):190-6
references.pmid: 14630990
references.citation: Hum Mutat. 2003 Jun;21(6):598-607
references.pmid: 12754706
references.citation: J Inherit Metab Dis. 2004;27(2):294-6
references.pmid: 15243991
references.citation: J Pediatr. 2003 Jun;142(6):684-9
references.pmid: 12838198
references.citation: Mol Genet Metab. 2005 Sep-Oct;86(1-2):124-33
references.pmid: 16040264
references.citation: Pediatrics. 2002 Jan;109(1):99-104
references.pmid: 11773547
references.citation: Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520
references.pmid: 15363638
references.citation: World J Gastroenterol. 2006 Dec 14;12(46):7397-404
references.pmid: 17167825
references.citation: Neuromuscul Disord. 2009 May;19(5):324-9
references.pmid: 19327992
references.citation: ILAR J. 2002;43(2):57-65
references.pmid: 11917157
references.citation: Mol Genet Metab. 2008 Aug;94(4):428-30
references.pmid: 18485779
references.citation: Lancet. 2007 Jan 6;369(9555):37-42
references.pmid: 17208640
references.citation: Pediatrics. 2006 Sep;118(3):1065-9
references.pmid: 16950999
references.citation: J Pediatr. 2003 Sep;143(3):335-42
references.pmid: 14517516
references.citation: J Perinat Med. 2007;35(1):76-8
references.pmid: 17313315
references.citation: Brain. 2007 Aug;130(Pt 8):2045-54
references.pmid: 17584774
references.citation: Biochem Biophys Res Commun. 2002 Oct 4;297(4):1033-42
references.pmid: 12359260
references.citation: Mol Genet Metab. 2005 Jun;85(2):108-14
references.pmid: 15896654
references.citation: Clin Genet. 2009 Aug;76(2):179-87
references.pmid: 19780764